BIONTECH SE
--------------------------------------- ----------- ------------
Total equity and liabilities EUR4,204.7 EUR2,318.6
--------------------------------------- ----------- ------------
Interim Condensed Consolidated Statements of Profit or Loss
Three months ended
March 31,
2021 2020
(in millions, except per share data) (unaudited) (unaudited)
------------------------------------- ------------ -----------
Revenues
Research & development revenues EUR20.9 EUR21.2
Commercial revenues 2,027.5 6.5
Total revenues 2,048.4 27.7
Cost of sales (233.1) (5.9)
Research and development expenses (216.2) (65.1)
Sales and marketing expenses (8.7) (0.5)
General and administrative expenses (38.9) (15.8)
Other operating expenses* (0.6) (0.1)
Other operating income* 111.3 0.4
---------------------------------------- ----------- -----------
Operating income / (loss) EUR1,662.2 EUR(59.3)
---------------------------------------- ----------- -----------
Finance income** 24.8 6.4
Finance expenses** (44.0) (0.1)
Interest expenses related to lease
liabilities (0.7) (0.4)
Profit / (loss) before tax EUR1,642.3 EUR(53.4)
---------------------------------------- ----------- -----------
Income taxes (514.2) -
---------------------------------------- ----------- -----------
Profit / (Loss) for the period EUR1,128.1 EUR(53.4)
---------------------------------------- ----------- -----------
Earnings per share
Basic profit / (loss) for the period
per share EUR4.64 EUR(0.24)
Diluted profit / (loss) for the period
per share EUR4.39 EUR(0.24)
* Foreign exchange differences related to operating activities on a
cumulative basis are either shown as other operating income or expenses
and might switch between those two positions during the year-to-date
reporting periods.
** Foreign exchange differences not related to operating activities on a
cumulative basis are either shown as finance income or expenses and
might switch between those two positions during the year-to-date
reporting periods.
Interim Condensed Consolidated Statements of Cash Flows
Three months ended
March 31,
2021 2020
(in millions) (unaudited) (unaudited)
------------------------------------------------------------- ------------ -----------
Operating activities
Profit / (Loss) for the period EUR1,128.1 EUR(53.4)
Income taxes 514.2 -
--------------------------------------------------------------- ----------- -----------
Profit / (loss) before tax EUR1,642.3 EUR(53.4)
--------------------------------------------------------------- ----------- -----------
Adjustments to reconcile profit / (loss) before tax
to net cash flows:
Depreciation and amortization of property, plant,
equipment and intangible assets 13.0 8.6
Share-based payment expense 17.3 8.4
Net foreign exchange differences (31.2) (0.3)
Gain on disposal of property, plant and equipment 0.2 0.1
Finance income (0.3) (0.4)
Interest on lease liability 0.7 0.4
Finance expense 44.0 0.1
Movements in government grants (67.9) -
Working capital adjustments:
Increase in trade and other receivables, contract
assets and other assets (2,100.5) (2.1)
Decrease / (Increase) in inventories (82.8) 2.2
(Decrease) / Increase in trade payables, other financial
liabilities, other liabilities, contract liabilities
and provisions 255.5 (17.9)
Interest received 0.3 0.3
Interest paid (1.8) (0.5)
Income tax paid (0.1) (0.2)
--------------------------------------------------------------- ----------- -----------
Net cash flows used in operating activities EUR(311.3) EUR(54.7)
--------------------------------------------------------------- ----------- -----------
Investing activities
Purchase of property, plant and equipment (21.7) (6.3)
Proceeds from sale of property, plant and equipment 0.9 -
Purchase of intangibles assets and right-of-use assets (7.5) (2.1)
Acquisition of subsidiaries and businesses, net of
cash acquired - (6.5)
Net cash flows used in investing activities EUR(28.3) EUR(14.9)
--------------------------------------------------------------- ----------- -----------
Financing activities
Proceeds from loans and borrowings - 2.9
Repayment of loans and borrowings (0.7) -
Payments related to lease liabilities (3.8) (0.9)
--------------------------------------------------------------- ----------- -----------
Net cash flows from/(used in) financing activities EUR(4.5) EUR2.0
--------------------------------------------------------------- ----------- -----------
Net decrease in cash and cash equivalents (344.1) (67.6)
Change in cash and cash equivalents resulting from
exchange rate differences 25.4 0.1
Cash and cash equivalents at January 1 1,210.2 519.1
--------------------------------------------------------------- ----------- -----------
Cash and cash equivalents at March 31 EUR891.5 EUR451.6
--------------------------------------------------------------- ----------- -----------
(END) Dow Jones Newswires
May 10, 2021 07:00 ET (11:00 GMT)
